Tetrac 20% is a broad-spectrum antibiotic with a bacteriostatic effect against both Gram-positive and Gram-negative bacteria, as well as Mycoplasma, by inhibiting protein synthesis within the bacterial cell.
Tetrac 20% is rapidly absorbed from the digestive tract and is excreted through urine and bile.
Tetrac 20% is characterized by its ability to distribute effectively throughout various body tissues with a high bioavailability.